Balyasny Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Sell |
199,989
-519,091
| -72% | -$4.2M | ﹤0.01% | 1242 |
|
|
2025
Q1 | $6.03M | Buy |
719,080
+546,767
| +317% | +$4.58M | 0.01% | 801 |
|
|
2024
Q4 | $1.36M | Buy |
+172,313
| New | +$1.36M | ﹤0.01% | 1199 |
|
|
2023
Q4 | – | Sell |
-29,594
| Closed | -$125K | – | 1892 |
|
|
2023
Q3 | $125K | Buy |
+29,594
| New | +$125K | ﹤0.01% | 1618 |
|
|
2020
Q2 | – | Sell |
-24,151
| Closed | -$84K | – | 939 |
|
|
2020
Q1 | $84K | Buy |
+24,151
| New | +$84K | ﹤0.01% | 958 |
|
|
2019
Q3 | – | Sell |
-32,834
| Closed | -$235K | – | 1016 |
|
|
2019
Q2 | $235K | Sell |
32,834
-95,287
| -74% | -$682K | ﹤0.01% | 1240 |
|
|
2019
Q1 | $1.82M | Buy |
128,121
+60,605
| +90% | +$859K | 0.01% | 756 |
|
|
2018
Q4 | $913K | Sell |
67,516
-4,958
| -7% | -$67K | 0.01% | 831 |
|
|
2018
Q3 | $1.61M | Buy |
+72,474
| New | +$1.61M | 0.01% | 850 |
|